It was shown that CD4-specific chimeric antigen receptor (CAR)-engineered T cells (CD4CAR T cells), when in co-culture with CD4+ T cell leukemic cell lines (KARPAS 299 cells, primary leukemia cells from a patient), eliminated CD4+ T leukemic cells [42]. The gene discussed is CD4; the disease is leukemia.